Cargando…
CARD14 mutations may predict response to antitumour necrosis factor‐α therapy in psoriasis: a potential further step towards personalized medicine
Linked Article: http://dx.doi.org/10.1111/bjd.14461.
Autores principales: | Wu, K.C.P., Reynolds, N.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961628/ https://www.ncbi.nlm.nih.gov/pubmed/27484270 http://dx.doi.org/10.1111/bjd.14795 |
Ejemplares similares
-
CARD14 Expression in Dermal Endothelial Cells in Psoriasis
por: Harden, Jamie L., et al.
Publicado: (2014) -
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis
por: Suleman, Saima, et al.
Publicado: (2022) -
The case for humour: Moving one step further
por: Andrade, Chittaranjan
Publicado: (2006) -
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS)
por: Signa, S, et al.
Publicado: (2015) -
Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
por: Kay, Emily J., et al.
Publicado: (2023)